We combine rigorous analytics, global insight,
and tailored strategies to help institutional investors achieve their financial and mission-driven goals.
Learn More
LATEST INSIGHTS //
Quarterly Letter – Q1 2026: War… But Do Investors Care?
Market behavior in Q1 was dominated by the war with Iran, with global oil prices soaring and equities collapsing after the February 28 attacks by the US and Israel. But after weeks of war, the extraordinary resilience of the US economy began to reassert itself. Creeping doubts about the profitability of AI had dampened performance before the war. But these and other concerns seemed to be cast aside at the end of Q1 as “buy the dip” fervor took over. It continued into April.
RESEARCH // April 24, 2026

FOCUS AREAS //

Customized investments to meet our partners' specific goals

Outsourced Chief Investment Officer (OCIO)

Partnering to catalyze sustainable growth

Multi-Asset Class Solutions

Accessing the full power of finance

Energy Innovation and Smart Futures

Marshalling returns that balance risk and impact

Emerging Investment Partners

Marshalling balanced insights for today’s dynamic world

We are proud to work with

Devoted Health

BioAge Labs

Antora

Raven SR

Apeel

Generate

Devoted Health

BioAge Labs

Antora

Raven SR

Go to Portfolio

Insights from RockCreek

Research

Quarterly Letter – Q1 2026: War… But Do Investors Care?

April 24, 2026

Market behavior in Q1 was dominated by the war with Iran, with global oil prices soaring and equities collapsing after the February 28 attacks by the US and Israel. But after weeks of war, the extraordinary resilience of the US economy began to reassert itself. Creeping doubts about the profitability of AI had dampened performance before the war. But these and other concerns seemed to be cast aside at the end of Q1 as “buy the dip” fervor took over. It continued into April.

Learn More